Flaherty & Crumrine Preferred Income Opportunity Fund (PFO)

QUOTE AND NEWS
MedPage Today  Apr 30  Comment 
(MedPage Today) -- Among healthy older adults who were followed for more than a decade, the presence of a patent foramen ovale (PFO) was not associated with ischemic stroke or subclinical cerebrovascular disease, researchers found.
MedPage Today  Mar 20  Comment 
(MedPage Today) -- The negative results of three randomized trials should have closed the book on patent foramen ovale closure in cryptogenic stroke, but the book is still being read.
Forbes  Mar 20  Comment 
Two controversial trials testing PFO closure with the Amplatzer PFO Occluder (St. Jude Medical) in patients with cryptogenic stroke, first presented last fall at the TCT meeting, have now been published in the New England Journal of Medicine....
Benzinga  Feb 8  Comment 
St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, today announced the presentation of additional data from its landmark RESPECT trial at the American Stroke Association's International Stroke Conference 2013 in Honolulu. The...
MedPage Today  Oct 29  Comment 
MIAMI (MedPage Today) -- When null findings are reported, the reaction of many clinicians is to seek a silver lining in secondary analyses, which is exactly what researchers did at the Transcatheter Cardiovascular Therapeutics meeting when they...
Benzinga  Oct 25  Comment 
St. Jude Medical, Inc. (NYSE: STJ), a medical device company, today announced results from its RESPECT trial, which studied the AMPLATZER™ PFO Occluder in the prevention of recurrent cryptogenic stroke. Evidence presented at...
MedPage Today  Oct 18  Comment 
MIAMI (MedPage Today) -- After disappointing results with closure of patent foramen ovale for cryptogenic stroke prevention in recent years, the procedure will be making headlines again at the Transcatheter Therapeutics meeting here.
Forbes  Jul 23  Comment 
(Updated at bottom with statement from St. Jude Medical)
MedPage Today  Jun 28  Comment 
(MedPage Today) -- For the first time, a patent foramen ovale (PFO) has been linked with the occurrence of a visual aura without the migraine headache, researchers found.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki